Initial Statement of Beneficial Ownership (3)
August 16 2017 - 6:04PM
Edgar (US Regulatory)
FORM 3
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES
|
OMB APPROVAL
OMB Number:
3235-0104
Estimated average burden
hours per response...
0.5
|
|
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
|
|
1. Name and Address of Reporting Person
*
Kreitzer Stephen M.
|
2. Date of Event Requiring Statement (MM/DD/YYYY)
8/16/2017
|
3. Issuer Name
and
Ticker or Trading Symbol
Advanzeon Solutions, Inc. [CHCR]
|
(Last)
(First)
(Middle)
4917 ANDROS DRIVE
|
4. Relationship of Reporting Person(s) to Issuer (Check all applicable)
_____ Director
_____ 10% Owner
_____ Officer (give title below)
___
X
___ Other (specify below)
/ Medical Director, PVMS, Inc.
|
(Street)
TAMPA, FL 33629
(City)
(State)
(Zip)
|
5. If Amendment, Date Original Filed
(MM/DD/YYYY)
|
6. Individual or Joint/Group Filing
(Check Applicable Line)
_
X
_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
|
Table I - Non-Derivative Securities Beneficially Owned
|
1.Title of Security
(Instr. 4)
|
2. Amount of Securities Beneficially Owned
(Instr. 4)
|
3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)
|
4. Nature of Indirect Beneficial Ownership
(Instr. 5)
|
Common Stock
|
97000
|
D
|
|
Table II - Derivative Securities Beneficially Owned (
e.g.
, puts, calls, warrants, options, convertible securities)
|
1. Title of Derivate Security
(Instr. 4)
|
2. Date Exercisable and Expiration Date
(MM/DD/YYYY)
|
3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)
|
4. Conversion or Exercise Price of Derivative Security
|
5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)
|
6. Nature of Indirect Beneficial Ownership
(Instr. 5)
|
Date Exercisable
|
Expiration Date
|
Title
|
Amount or Number of Shares
|
Warrant
|
2/17/2016
|
2/17/2019
|
Common Stock
|
100000
|
$.25
|
D
|
|
Warrant
|
3/17/2016
|
3/17/2019
|
Common Stock
|
100000
|
$.25
|
D
|
|
Warrant
|
4/17/2016
|
4/17/2019
|
Common Stock
|
100000
|
$.25
|
D
|
|
Warrant
|
5/17/2016
|
5/17/2019
|
Common Stock
|
100000
|
$.25
|
D
|
|
Warrant
|
6/17/2016
|
6/17/2019
|
Common Stock
|
100000
|
$.25
|
D
|
|
Warrant
|
7/7/2016
|
7/7/2021
|
Common Stock
|
200000
|
$.15
|
D
|
|
Warrant
|
2/17/2017
|
2/17/2017
|
Common Stock
|
500000
|
$.25
|
D
|
|
$100,000 Convertible Promissory Note
|
7/24/2017
|
7/24/2018
|
Common Stock
|
(1)
|
(1)
|
D
|
|
Explanation of Responses:
|
(1)
|
The Holder shall have the right to convert all or a portion of the Note, along with accrued and unpaid interest, into shares of the common stock of the Parent at a per share price equal to the lesser of (i) 15% below the average daily closing bid price of the Parent's common stock for the immediate predeing twenty (20) business days; or, (ii) $0.11. The Holder shall submit a Conversion Notice indicating his/her election to convert and the amount being converted. The Note has a Maturity Date of 12 months.
|
Reporting Owners
|
Reporting Owner Name / Address
|
Relationships
|
Director
|
10% Owner
|
Officer
|
Other
|
Kreitzer Stephen M.
4917 ANDROS DRIVE
TAMPA, FL 33629
|
|
|
|
Medical Director, PVMS, Inc.
|
Signatures
|
/s/Stephen M. Kreitzer
|
|
8/8/2017
|
**
Signature of Reporting Person
|
Date
|
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
|
*
|
If the form is filed by more than one reporting person,
see
Instruction 5(b)(v).
|
**
|
Intentional misstatements or omissions of facts constitute Federal Criminal Violations.
See
18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
|
Note:
|
File three copies of this Form, one of which must be manually signed. If space is insufficient,
see
Instruction 6 for procedure.
|
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
|